Humira
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
It's the best-selling drug by revenue worldwide and manufacturer AbbVie has worked hard to fend off competition. Very hard…
The Patent Trial and Appeal Board (PTAB) found all of the claims of three AbbVie Biotechnology Ltd. (AbbVie) patents directed to…
NEW DRUG APPROVALS Amjevita, the First Humira Biosimilar The FDA has approved Amjevita (adalimumab-atto, Amgen) as a bio similar…
Objectives: To review a cohort of patients receiving higher than standard or FDA approved dosing of TNF
inhibitors to assess the…
The AbbVie purchase of Shire for about $54 billion will create one of the biggest deals so far this year.
Abstract Humira, an anti-TNF drug aimed at decreasing inflammation in Rheumatoid Arthritis patients, can cause skin diseases from…
Abbott a reçu l’autorisation de mise sur le marché par la Food and Drug Administration (FDA) aux Etats-Unis pour HUMIRA…